(-)-TERPINEN-4-OL

CAS No. 20126-76-5

(-)-TERPINEN-4-OL( —— )

Catalog No. M23903 CAS No. 20126-76-5

Terpinen-4-ol can be used as an antibacterial and antibiofilm agent against Staphylococcus aureus.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G 31 In Stock

Biological Information

  • Product Name
    (-)-TERPINEN-4-OL
  • Note
    Research use only, not for human use.
  • Brief Description
    Terpinen-4-ol can be used as an antibacterial and antibiofilm agent against Staphylococcus aureus.
  • Description
    Terpinen-4-ol can be used as an antibacterial and antibiofilm agent against Staphylococcus aureus.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    20126-76-5
  • Formula Weight
    154.25
  • Molecular Formula
    C10H18O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (648.30 mM)
  • SMILES
    CC(C)[C@@]1(CC=C(C)CC1)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Cordeiro L, Figueiredo P, Souza H, Sousa A, Andrade-Júnior F, Medeiros D, Nóbrega J, Silva D, Martins E, Barbosa-Filho J, Lima E. Terpinen-4-ol as an Antibacterial and Antibiofilm Agent against Staphylococcus aureus. Int J Mol Sci. 2020 Jun 25;21(12):4531.
molnova catalog
related products
  • Prothioconazole

    Prothioconazole is a chiral triazole fungicide in plant pathogen control.

  • TH1020

    TH1020 is a novel Inhibitor of Toll-Like Receptor 5 (TLR5)/Flagellin Complex with promising activity (IC50 =0.85±0.12?μm) and specificity.

  • QcrB inhibitor TB47

    QcrB inhibitor TB47 (TB47) is a novel antimycobacterial agent that fuctions as a putative respiratory complex III (QcrB) inhibitor with MIC of 0.016-0.5 ug/mL against a panel of 56 M.